Columbia University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Columbia University sits in the top decile of US sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count).
Columbia University: 958 sponsored US clinical trials, 171 recruiting.
Columbia University sponsors 958 registered US clinical trials on ClinicalTrials.gov, 171 of them currently recruiting, and 597 completed. 88 of these trials are in Phase 3-4 (later-stage) and 191 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 9 trials.
Top-decile sponsor footprint
Columbia University ranks in the top decile of sponsors by registered trial count (#34 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
597 of 736 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
958 total, page 3 of 20
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
NCT05553457
Vascular Endothelial Dysfunction in Sleep Apnea
NCT05289063
ETE Interventions in the Dental Setting
NCT05584501
Enhanced Nutritional Optimization in LVAD Trial
NCT05655910
Genomic Uniformed-Screening Against Rare Disease In All Newborns
NCT05990179
Hypoparathyroidism Natural History Study
NCT05793853
Postpartum Hypertension Study
NCT05139238
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
NCT05353322
R-MVST Cells for Treatment of Viral Infections
NCT05183490
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
NCT05351424
Pictographs for Preventing Wrong-Patient Errors in NICUs
NCT03960099
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)
NCT05219695
Lifestyle Patterns and Glycemic Control
NCT05224986
Stress Phenotypes and Preterm Birth
NCT05229666
RFA Treatment for Papillary Thyroid Microcarcinoma
NCT05189821
Stick2PrEP Cisgender Women and Trans Individuals
NCT05165745
Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation
NCT04804891
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
NCT05304858
Spinal Cord Associative Plasticity Study
NCT05163639
StrataCTX® as a Steroid Sparing Device
NCT04087629
CU-COMMITS: COVID-19 Care in Black and Latino Communities and Households. Clinical and Molecular Outcomes of SARS-CoV-2
NCT05467930
Breast Elasticity Imaging During Neoadjuvant Chemotherapy
NCT04824027
Isatuximab in Patients With Monoclonal Gammopathy of Renal Significance
NCT04614558
Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease
NCT04840979
Photopheresis in Early-stage Mycosis Fungoides
NCT05680558
How is Social Connection Represented in the Brain?
NCT04577911
Study of BEST1 Vitelliform Macular Dystrophy
NCT05809635
Longitudinal Oral Microbiome Sampling for BE
NCT05133102
Brain Research Apprenticeships in New York at Columbia
NCT04728022
Measuring Physical Activity With ActivPal
NCT06084026
Opioid Dispensing Device for Post-Operative Pain in Cancer Patients
NCT05585788
Radiofrequency Ablation for BIII Thyroid Nodules
NCT05189808
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
NCT02314988
ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
NCT04367857
Determinants of SARS (Severe Acute Respiratory Syndrome)-COV2 (COVID-19) Persistence After Convalescence
NCT04448145
Targeted Fortification of Donor Breast Milk in Preterm Infants
NCT04294368
MyHand 2: An Active Hand Orthosis for Stroke Patients
NCT04436042
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment
NCT03891160
Osteochondral Allograft in the Surgical Treatment of Basal Joint Arthritis
NCT03722537
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study
NCT05189314
e-Connect: A Service System Intervention for Justice Youth at Risk for Suicide
NCT03586895
Postpartum Low-Dose Aspirin and Preeclampsia
NCT03667326
Recovery of Consciousness Following Intracerebral Hemorrhage
NCT03990558
The Impact of Glomerular Disorders on Bone Quality and Strength
NCT04528446
Autoimmune Features of Neurodegenerative Disorders
NCT04239079
Navio Robotic Versus Conventional Total Knee Arthroplasty
NCT03519269
CNGB1 and Allied Disorders
NCT04639635
Circadian Misalignment and Energy Balance
NCT03663530
Amyotrophic Lateral Sclerosis (ALS) Families Project
NCT03865420
Effect of Giving Reduced Fluid in Children After Trauma
NCT04201704
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 105 |
| Phase 3 | 23 |
| Phase 4 | 65 |
Therapeutic Areas
What is open in the Columbia University pipeline
171 recruiting of 958 indexed (18% open); 597 completed (62%).
Phase mix: 88 late (III/IV) vs 191 early (I/II) (early-phase heavy).
Top condition: Obesity (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Columbia University: open-pipeline peers nationwide
Peers matched on 958 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Columbia University sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 958 trials (± recruiting share)
- University of Minnesota · 966 trials · 19% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- University of California, Los Angeles · 897 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Kite, A Gilead Company · 18% recruiting · 28 trials
- Mirum Pharmaceuticals · 18% recruiting · 28 trials
- West Virginia University · 18% recruiting · 122 trials
- Hospital for Special Surgery, New York · 18% recruiting · 194 trials
Related
What to do with this Columbia University page
958 registered trials is a research-attention snapshot, not an endorsement of Columbia University or any single study.
- 171 of Columbia University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Columbia University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Columbia University pipeline card: 958 registered trials from official public datasets.Report a data error.